682 related articles for article (PubMed ID: 33586496)
1. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the renin-angiotensin-aldosterone system and renal Kir5.1 channels.
Manis AD; Palygin O; Khedr S; Levchenko V; Hodges MR; Staruschenko A
Clin Sci (Lond); 2019 Dec; 133(24):2449-2461. PubMed ID: 31799617
[TBL] [Abstract][Full Text] [Related]
3. SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na
Kravtsova O; Bohovyk R; Levchenko V; Palygin O; Klemens CA; Rieg T; Staruschenko A
Am J Physiol Renal Physiol; 2022 Jun; 322(6):F692-F707. PubMed ID: 35466690
[TBL] [Abstract][Full Text] [Related]
4. Central and peripheral slow-pressor mechanisms contributing to Angiotensin II-salt hypertension in rats.
Lu J; Wang HW; Ahmad M; Keshtkar-Jahromi M; Blaustein MP; Hamlyn JM; Leenen FHH
Cardiovasc Res; 2018 Feb; 114(2):233-246. PubMed ID: 29126194
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
[TBL] [Abstract][Full Text] [Related]
6. Chronic angiotensin II infusion drives extensive aldosterone-independent epithelial Na+ channel activation.
Mamenko M; Zaika O; Prieto MC; Jensen VB; Doris PA; Navar LG; Pochynyuk O
Hypertension; 2013 Dec; 62(6):1111-1122. PubMed ID: 24060890
[TBL] [Abstract][Full Text] [Related]
7. Salt-sensitive hypertension in chronic kidney disease: distal tubular mechanisms.
Bovée DM; Cuevas CA; Zietse R; Danser AHJ; Mirabito Colafella KM; Hoorn EJ
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F729-F745. PubMed ID: 32985236
[TBL] [Abstract][Full Text] [Related]
8. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.
Zhu A; Yoneda T; Demura M; Karashima S; Usukura M; Yamagishi M; Takeda Y
J Hypertens; 2009 Apr; 27(4):800-5. PubMed ID: 19516179
[TBL] [Abstract][Full Text] [Related]
9. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
[TBL] [Abstract][Full Text] [Related]
10. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats.
Huang BS; White RA; Jeng AY; Leenen FH
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R994-R1000. PubMed ID: 19118098
[TBL] [Abstract][Full Text] [Related]
11. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
[TBL] [Abstract][Full Text] [Related]
12. (Pro)Renin receptor regulates potassium homeostasis through a local mechanism.
Xu C; Lu A; Wang H; Fang H; Zhou L; Sun P; Yang T
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F641-F656. PubMed ID: 27440776
[TBL] [Abstract][Full Text] [Related]
13. Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease.
Taylor AHM; Rankin AJ; McQuarrie EP; Freel EM; Homer NZM; Andrew R; Jardine AG; Mark PB
Clin Sci (Lond); 2018 Jan; 132(2):285-294. PubMed ID: 29321218
[TBL] [Abstract][Full Text] [Related]
14. K+-induced natriuresis is preserved during Na+ depletion and accompanied by inhibition of the Na+-Cl- cotransporter.
van der Lubbe N; Moes AD; Rosenbaek LL; Schoep S; Meima ME; Danser AH; Fenton RA; Zietse R; Hoorn EJ
Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1177-88. PubMed ID: 23986520
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
Kawarazaki W; Fujita T
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
[TBL] [Abstract][Full Text] [Related]
16. Determinants of renal oxygen metabolism during low Na
Patinha D; Carvalho C; Persson P; Pihl L; Fasching A; Friederich-Persson M; O'Neill J; Palm F
J Physiol; 2020 Dec; 598(23):5573-5587. PubMed ID: 32857872
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.
Kawarazaki W; Nagase M; Yoshida S; Takeuchi M; Ishizawa K; Ayuzawa N; Ueda K; Fujita T
J Am Soc Nephrol; 2012 Jun; 23(6):997-1007. PubMed ID: 22440899
[TBL] [Abstract][Full Text] [Related]
18. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.
Susic D; Varagic J; Frohlich ED
Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1177-81. PubMed ID: 20118410
[TBL] [Abstract][Full Text] [Related]
20. Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension.
Devarajan S; Yahiro E; Uehara Y; Habe S; Nishiyama A; Miura S; Saku K; Urata H
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1987-96. PubMed ID: 26432844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
